Package Leaflet: Information for the User
ENTECAVIR DR. REDDYS 0.5 MG FILM-COATED TABLETS EFG
Entecavir
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Entecavir is an antiviral medicine used to treat long-term (chronic) hepatitis B virus (HBV) infection in adults.
Entecavir may be used in patients whose liver is damaged but still works adequately (compensated liver disease) and in patients whose liver is damaged and does not work adequately (decompensated liver disease).
Entecavir is also used to treat long-term (chronic) HBV infection in children and adolescents from 2 to less than 18 years of age.
Entecavir may be used in children whose liver is damaged but still works adequately (compensated liver disease).
Hepatitis B virus infection can damage your liver. Entecavir reduces the amount of virus in your body and improves liver condition.
Do not take Entecavir Dr. Reddys
Warnings and precautions
Talk to your doctor or pharmacist before taking entecavir
Children and adolescents
Entecavir should not be used in children under 2 years of age or weighing less than 10 kg.
Taking Entecavir Dr. Reddys with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking Entecavir Dr. Reddys with food and drinks
In most cases, you can take entecavir with or without food. However, if you have received previous treatment with another medicine containing lamivudine as the active ingredient, you should consider the following. If you have switched to entecavir because lamivudine treatment was not successful, you should take entecavir on an empty stomach, once a day. If your liver disease is very advanced, your doctor will also instruct you on taking entecavir on an empty stomach.
An empty stomach means at least 2 hours after and 2 hours before the next meal.
Children and adolescents (from 2 to less than 18 years of age) can take entecavir with or without food.
Pregnancy, breastfeeding, and fertility
Tell your doctor if you are pregnant or planning to become pregnant. The use of entecavir has not been shown to be safe during pregnancy. Entecavir should not be used during pregnancy unless clearly necessary, as determined by your doctor. It is important that women of childbearing age using entecavir use an effective method of contraception to prevent pregnancy.
You should not breastfeed during treatment with entecavir. If you are breastfeeding, tell your doctor. It is not known whether entecavir, the active ingredient of this medicine, is excreted in breast milk.
Driving and using machines
Dizziness, fatigue, and somnolence are common side effects that may affect your ability to drive and use machines. If you are unsure, consult your doctor.
Entecavir Dr. Reddys contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Not all patients need to take the same dose of entecavir.
Follow exactly the instructions of administration of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
For adultsthe recommended dose is 0.5 mg or 1 mg once a day (by mouth).
Your dose will depend on:
For children and adolescents(from 2 to less than 18 years of age), your pediatrician will decide the appropriate dose based on the child's body weight. Children weighing at least 32.6 kg can take the oral solution or the 0.5 mg tablets. Entecavir oral solution is recommended for patients with a weight between 10 kg and 32.5 kg. All doses should be taken once a day (by mouth). There are no recommendations for entecavir in children under 2 years of age or weighing less than 10 kg.
Your doctor will advise you on the correct dose for you. Always take the dose recommended by your doctor to ensure that the medicine is fully effective and to reduce the development of resistance to treatment. Take entecavir for as long as your doctor has told you. Your doctor will tell you when to stop treatment.
Some patients must take entecavir on an empty stomach (see Entecavir Dr. Reddys with food and drinksin Section 2). If your doctor tells you to take entecavir on an empty stomach, an empty stomach means at least 2 hours after a meal and 2 hours before the next meal.
If you take more Entecavir Dr. Reddys than you should
Contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Entecavir Dr. Reddys
It is important that you do not miss any dose. If you miss a dose of entecavir, take it as soon as possible and then take the next scheduled dose at the usual time. If it is almost time for your next dose, do not take the missed dose. Wait and take the next dose at the usual time. Do not take a double dose to make up for missed doses.
Do not stop taking Entecavir Dr. Reddys without talking to your doctor
Some people develop very severe hepatitis symptoms when they stop taking entecavir. Tell your doctor immediately about any changes in symptoms you notice after stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Patients treated with entecavir have reported the following side effects:
Adults
Children and adolescents
The side effects experienced in children and adolescents are similar to those experienced in adults as described above, with the following difference:
Very common (at least 1 in 10 patients): low levels of neutrophils (a type of white blood cell important in fighting infection).
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible that they are not listed in this leaflet.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible that they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Information System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Do not store above 30°C. Store in the original package.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Entecavir Dr. Reddys
The active substance is entecavir. Each film-coated tablet contains entecavir monohydrate equivalent to 0.5 mg of entecavir.
The other ingredients are:
Core of the tablet: lactose monohydrate, microcrystalline cellulose (E460), pregelatinized corn starch, crospovidone (Type A) (E1202), and magnesium stearate.
Coating of the tablet: titanium dioxide (E171), hypromellose (E464), macrogol 400 (E1521), and polysorbate 80 (E433).
Appearance of the product and pack contents
Entecavir Dr. Reddys 0.5 mg film-coated tablets are white, oval-shaped, and have a score line on both sides.
Entecavir Dr. Reddys 0.5 mg is supplied in boxes containing 10 x 1, 30 x 1, 60 x 1, or 90 x 1 film-coated tablets in unit dose blisters.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Reddy Pharma Iberia, S.A.
Avda Josep Tarradellas, nº 38
08029 Barcelona
Spain
Phone: 93 355 49 16
Fax: 93 355 49 61
Manufacturer:
Medis International a.s
výrobní závod Bolatice
Prumyslová 961/16, 747 23 Bolatice
Czech Republic
This medicine is authorised in the Member States of the EU under the following names:
Holada: Entecavir Dr. Reddy’s 0.5 mg Filmomhulde tabletten
Germany: Entecavir beta 0.5 mg Filmtabletten
Spain: Entecavir Dr. Reddys 0.5 mg comprimidos recubiertos con película EFG
Italy: Entecavir Dr. Reddy’s
Romania: Entecavir Dr. Reddy’s 0.5 mg comprimate filmate
United Kingdom: Entecavir Dr. Reddy’s 0.5 mg film-coated tablets
Date of last revision of this leaflet:December 2020
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es